# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Benchmark analyst Bruce Jackson reiterates Know Labs (AMEX:KNW) with a Speculative Buy and maintains $1 price target.
Know Labs (AMEX:KNW) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 4...
The Company's oral abstract presentation features results from its clinical study that demonstrate the accuracy and medical...
Benchmark analyst Bruce Jackson initiates coverage on Know Labs (AMEX:KNW) with a Speculative Buy rating and announces Price...
Shares of NetApp, Inc. (NASDAQ: NTAP) shares rose sharply in today’s pre-market trading after the company reported better-than...
Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has entered...
The KnowU incorporates the sensor intended for FDA submissionKnow Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive ...
Know Labs (AMEX:KNW) reported quarterly losses of $(0.04) per share. This is a 50 percent increase over losses of $(0.08) per s...
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on r...